Updates In IDHm GLIOMAS

Updates on IDHm Gliomas: Current and Emerging Treatments Description: 

This session will provide updates on the treatment of IDH-mutant gliomas (IDHm gliomas), focusing on existing and emerging therapies. It will cover the role of IDH inhibitors, challenges in treatment, and the latest clinical research on managing these tumors. 

Target Audience: Oncology professionals, neuro-oncologists, and clinicians involved in glioma care. Learning 

Objectives: By the end of this program, participants will be able to: 

1. Identify current and emerging treatments for IDHm gliomas. 
2. Understand challenges in managing IDHm gliomas, including resistance and tumor heterogeneity. 
3. Understand the role of IDH inhibitors in the treatment of IDHm gliomas.

This is non-CE program